Oct 29, 2015

Shareholder Update October 2015

In this Issue:

› EU marketing approval granted for VivaGel^® BV
› Multi-product DEP^® license with AstraZeneca
› VivaGel^® BV: Symptomatic Relief and Treatment of BV/Prevention of recurrence
› VivaGel^® condom
› Phase 1 DEP® docetaxel trial update                                                                                    

› Agrochemicals
› Starpharma in the News
› Starpharma full year financial results      

› Presentations and conferences

Download: Shareholder Update October 2015 (pdf file, 994kb)

 This contains certain forward-looking statements.